# Volitionrx Ltd: insider transactions

VNRX · NYSE · CIK 93314 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vnrx.md) · [Financials](/companies/vnrx/financials.md) · [Filings](/companies/vnrx/filings.md) · [Insiders](/companies/vnrx/insiders.md)

## All transactions: 1

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Batchelor Ann-Louise](/insiders/1945612.md) | Group Chief Marketing Officer, Officer | Grant or award (A) | 12,000 | $0.00 | $0 | [Form 4](/filings/0001477932-26-006439.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 17:01 ET. No prices; not investment advice.